{"data":{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:32642801", "kind": "science-record", "revision": 8, "content_hash": "sha256:eff1692b5e6795fa94776956bc169137c19f6ad62ff18d9f9381d76fa9af7040", "created_at": "2026-11-01T15:41:05Z", "updated_at": "2026-11-01T22:01:54Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.", "doi": "10.1007/s12031-020-01620-w", "pmid": "32642801", "authors": ["Chunxiao Qi", "Lei Lei", "Jinqu Hu", "Gang Wang", "Jiyuan Liu", "Shaowu Ou"], "journal": "Journal of molecular neuroscience : MN", "year": 2020, "abstract": "Serine Incorporator 2 (SERINC2) is a transmembrane protein that incorporates serine into membrane lipids. The function of SERINC2 in tumors has been reported, but the role of SERINC2 in gliomas is not fully understood. RNA-sequencing data from The Cancer Genome Atlas (TCGA) (530 cases of low-grade glioma (LGG) and 173 cases of glioblastoma multiforme (GBM)) and microarray data from Gene Expression Omnibus (GEO) (Accession No. GSE16011, 284 cases gliomas were included) were acquired. Bioinformatics analysis was performed as the primary method to examine the function of SERINC2 and its correlated genes in glioma. SERINC2 was highly expressed in GBM compared with LGG and normal brain tissues. Elevated SERINC2 expression predicted shorter 5-, 10-, and 15-year overall survival (OS) of LGG patients and isocitrate dehydrogenase-1 (IDH-1) mutation-type LGG patients but had no effect on the OS of GBM patients. Cox regression analysis showed that SERINC2 was an independent factor in LGG OS. Methylation analysis found that 13 CpG methylation sites (methylation450k) correlated with SERINC2 expression in LGG. The mRNA expression level of SERINC2 was significant lower in the DNA deletion group than in the intact and amplification groups. A total of 390 copositive and 244 conegative correlation genes with SERINC2 were obtained from LGG in TCGA-LGG and GSE16011. Gene ontology (GO) category and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses showed that the copositive correlation genes were primarily enriched in the mitotic process and cell cycle. Combining the results from the protein-protein interaction (PPI) network of SERINC2 correlation genes and CytoHubba led to the selection of 10 hub genes (CDC20, FN1, AURKB, AURKA, KIF2C, BIRC5, CCNB2, UBE2C, CCNA2, and CENPE). OncoLnc analysis confirmed that high expression levels of these hub genes were associated with poor OS in LGG. Our results suggested that aberrant SERINC2 expression existed in glioma and that its expression might be a potential prognostic marker in LGG patients. CDC20, FN1, AURKB, AURKA, KIF2C, BIRC5, CCNB2, UBE2C, CCNA2, and CENPE may be potential biomarkers and therapeutic targets for LGG.", "claims": [{"id": "claim-method", "statement": "Kaplan-Meier survival analysis was performed to compare the OS data in the two cohorts.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32642801", "locator": "sections[4] \"Statistical Analysis\" paragraph 2", "quote": "Kaplan-Meier survival analysis was performed to compare the OS data in the two cohorts."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The present study was based on RNA sequencing data from TCGA-LGG (530 cases, Illumina HiSeq 2000 RNA Sequencing platform) and TCGA-GBM (173 cases, Illumina HiSeq 2000 RNA Sequencing platform) and microarray data from GSE16011, which contains 8 cases of normal brain tissue as a control group, 159 cases of GBM, and 117 cases of low-grade gliomas (GPL8542 platform, Affymetrix GeneChip Human Genome U133 Plus 2.0 Array).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32642801", "locator": "sections[3] \"Data Collection and Bioinformatics Analysis\" paragraph 2", "quote": "The present study was based on RNA sequencing data from TCGA-LGG (530 cases, Illumina HiSeq 2000 RNA Sequencing platform) and TCGA-GBM (173 cases, Illumina HiSeq 2000 RNA Sequencing platform) and microarray data from GSE16011, which contains 8 cases of normal brain tissue as a control group, 159 cases of GBM, and 117 cases of low-grade gliomas (GPL8542 platform, Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:32642801"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE16011"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE16011"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:32642801", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1007/s12031-020-01620-w", "sha256": "sha256:5fc218735774b4ca3a62701e7afe169b6333c4dcff59287db55aba7f7bd92183", "bytes": 31949, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1007/s12031-020-01620-w", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC7497444", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE16011", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16011", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE16011", "version": null, "note": "The present study was based on RNA sequencing data from TCGA-LGG (530 cases, Illumina HiSeq 2000 RNA Sequencing platform) and TCGA-GBM (173 cases, Illumina HiSeq 2000 RNA Sequencing platform) and microarray data from GSE16011, which contains 8 cases of normal brain tissue as a control group, 159 cases of GBM, and 117 cases of low-grade gliomas (GPL8542 platform, Affymetrix GeneChip Human Genome U133 Plus 2.0 Array).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The present study was based on RNA sequencing data from TCGA-LGG (530 cases, Illumina HiSeq 2000 RNA Sequencing platform) and TCGA-GBM (173 cases, Illumina HiSeq 2000 RNA Sequencing platform) and microarray data from GSE16011, which contains 8 cases of normal brain tissue as a control group, 159 cases of GBM, and 117 cases of low-grade gliomas (GPL8542 platform, Affymetrix GeneChip Human Genome U133 Plus 2.0 Array).", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM405200", "GSM405201", "GSM405202", "GSM405203", "GSM405204", "GSM405205", "GSM405206", "GSM405207", "GSM405208", "GSM405209", "GSM405210", "GSM405211", "GSM405212", "GSM405213", "GSM405214", "GSM405215", "GSM405216", "GSM405217", "GSM405218", "GSM405219", "GSM405220", "GSM405221", "GSM405222", "GSM405223", "GSM405224", "GSM405225", "GSM405226", "GSM405227", "GSM405228", "GSM405229", "GSM405230", "GSM405231", "GSM405232", "GSM405233", "GSM405234", "GSM405235", "GSM405236", "GSM405237", "GSM405238", "GSM405239", "GSM405240", "GSM405241", "GSM405242", "GSM405243", "GSM405244", "GSM405245", "GSM405246", "GSM405247", "GSM405248", "GSM405249", "GSM405250", "GSM405251", "GSM405252", "GSM405253", "GSM405254", "GSM405255", "GSM405256", "GSM405257", "GSM405258", "GSM405259", "GSM405260", "GSM405261", "GSM405262", "GSM405263", "GSM405264", "GSM405265", "GSM405266", "GSM405267", "GSM405268", "GSM405269", "GSM405270", "GSM405271", "GSM405272", "GSM405273", "GSM405274", "GSM405275", "GSM405276", "GSM405277", "GSM405278", "GSM405279", "GSM405280", "GSM405281", "GSM405282", "GSM405283", "GSM405284", "GSM405285", "GSM405286", "GSM405287", "GSM405288", "GSM405289", "GSM405290", "GSM405291", "GSM405292", "GSM405293", "GSM405294", "GSM405295", "GSM405296", "GSM405297", "GSM405298", "GSM405299", "GSM405300", "GSM405301", "GSM405302", "GSM405303", "GSM405304", "GSM405305", "GSM405306", "GSM405307", "GSM405308", "GSM405309", "GSM405310", "GSM405311", "GSM405312", "GSM405313", "GSM405314", "GSM405315", "GSM405316", "GSM405317", "GSM405318", "GSM405319", "GSM405320", "GSM405321", "GSM405322", "GSM405323", "GSM405324", "GSM405325", "GSM405326", "GSM405327", "GSM405328", "GSM405329", "GSM405330", "GSM405331", "GSM405332", "GSM405333", "GSM405334", "GSM405335", "GSM405336", "GSM405337", "GSM405338", "GSM405339", "GSM405340", "GSM405341", "GSM405342", "GSM405343", "GSM405344", "GSM405345", "GSM405346", "GSM405347", "GSM405348", "GSM405349", "GSM405350", "GSM405351", "GSM405352", "GSM405353", "GSM405354", "GSM405355", "GSM405356", "GSM405357", "GSM405358", "GSM405359", "GSM405360", "GSM405361", "GSM405362", "GSM405363", "GSM405364", "GSM405365", "GSM405366", "GSM405367", "GSM405368", "GSM405369", "GSM405370", "GSM405371", "GSM405372", "GSM405373", "GSM405374", "GSM405375", "GSM405376", "GSM405377", "GSM405378", "GSM405379", "GSM405380", "GSM405381", "GSM405382", "GSM405383", "GSM405384", "GSM405385", "GSM405386", "GSM405387", "GSM405388", "GSM405389", "GSM405390", "GSM405391", "GSM405392", "GSM405393", "GSM405394", "GSM405395", "GSM405396", "GSM405397", "GSM405398", "GSM405399", "GSM405400", "GSM405401", "GSM405402", "GSM405403", "GSM405404", "GSM405405", "GSM405406", "GSM405407", "GSM405408", "GSM405409", "GSM405410", "GSM405411", "GSM405412", "GSM405413", "GSM405414", "GSM405415", "GSM405416", "GSM405417", "GSM405418", "GSM405419", "GSM405420", "GSM405421", "GSM405422", "GSM405423", "GSM405424", "GSM405425", "GSM405426", "GSM405427", "GSM405428", "GSM405429", "GSM405430", "GSM405431", "GSM405432", "GSM405433", "GSM405434", "GSM405435", "GSM405436", "GSM405437", "GSM405438", "GSM405439", "GSM405440", "GSM405441", "GSM405442", "GSM405443", "GSM405444", "GSM405445", "GSM405446", "GSM405447", "GSM405448", "GSM405449", "GSM405450", "GSM405451", "GSM405452", "GSM405453", "GSM405454", "GSM405455", "GSM405456", "GSM405457", "GSM405458", "GSM405459", "GSM405460", "GSM405461", "GSM405462", "GSM405463", "GSM405464", "GSM405465", "GSM405466", "GSM405467", "GSM405468", "GSM405469", "GSM405470", "GSM405471", "GSM405472", "GSM405473", "GSM405474", "GSM405475", "GSM405476", "GSM405477", "GSM405478", "GSM405479", "GSM405480", "GSM405481", "GSM405482", "GSM405483"], "sample_count": 284, "group_sizes": null, "group_sizes_basis": null, "platform": "8542", "taxon": "Homo sapiens", "title": "Intrinsic Gene Expression Profiles of Gliomas are a Better Predictor of Survival than Histology", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:32642801:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:33b1eee53b98a2fcbec98110ab967ff43c59a79d345dec5aa08bca5cabc4d7d4", "bytes": 1114, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[7]/table-wrap[1]#Tab1", "version": null, "note": "Cox regression results of SERINC2 among 21 tumor types", "structure": {"pmcid": "PMC7497444", "section_index": 7, "section_title": "High Expression of SERINC2 Predicts Poor Prognosis of LGG", "row_count": 22, "column_count": 4}, "table": {"label": "Table 1", "caption": "Cox regression results of SERINC2 among 21 tumor types", "rows": [["Cancer", "Cox coefficient", "P value", "FDR corrected P value"], ["LGG", "0.412", "2.60E-05", "1.70E-04"], ["PAAD", "0.151", "1.60E-01", "3.52E-02"], ["SARC", "0.224", "2.10E-02", "1.51E-01"], ["KIRP", "− 0.283", "5.90E-02", "1.65E-01"], ["SKCM", "0.138", "5.00E-02", "1.72E-01"], ["CESC", "0.351", "9.80E-03", "1.75E-01"], ["BLCA", "− 0.149", "6.40E-02", "2.56E-01"], ["LIHC", "0.143", "1.30E-01", "3.65E-01"], ["HNSC", "0.120", "9.90E-02", "4.09E-01"], ["LUAD", "0.095", "2.40E-01", "4.82E-01"], ["COAD", "− 0.160", "1.20E-01", "5.12E-01"], ["KIRC", "− 0.071", "3.80E-01", "5.12E-01"], ["LAML", "0.148", "1.60E-01", "5.54E-01"], ["STAD", "0.041", "6.30E-01", "8.78E-01"], ["LUSC", "0.041", "5.60E-01", "8.86E-01"], ["OV", "0.042", "6.00E-01", "9.21E-01"], ["GBM", "− 0.057", "5.50E-01", "9.28E-01"], ["BRCA", "− 0.016", "8.50E-01", "9.47E-01"], ["UCEC", "− 0.212", "7.60E-02", "9.58E-01"], ["READ", "− 0.141", "4.70E-01", "9.65E-01"], ["ESCA", "0.151", "3.00E-01", "9.77E-01"]], "row_count": 22, "column_count": 4, "numeric_cells": 63, "header_rows": 1, "locator": "section[7]/table-wrap[1]#Tab1"}}, {"id": "asset:table:pmid:32642801:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:fc72e9bae22ddab945f4f2030abc8ae27792acae24d62b5edf20eeb9c8c86f45", "bytes": 657, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#Tab2", "version": null, "note": "Cox regression results of ten hub genes in LGG", "structure": {"pmcid": "PMC7497444", "section_index": 12, "section_title": "Effect of 10 Hub Genes on OS of LGG", "row_count": 11, "column_count": 4}, "table": {"label": "Table 2", "caption": "Cox regression results of ten hub genes in LGG", "rows": [["Genes", "Cox coefficient", "P value", "FDR corrected P value"], ["CDC20", "0.534", "4.80E-07", "6.98E-06"], ["FN1", "0.309", "1.20E-03", "4.06E-03"], ["AURKB", "0.388", "2.00E-04", "8.98E-04"], ["AURKA", "0.391", "3.30E-04", "1.36E-03"], ["KIF2C", "0.582", "6.00E-08", "1.35E-06"], ["BIRC5", "0.360", "3.40E-04", "1.39E-03"], ["CCNB2", "0.464", "8.70E-06", "6.87E-05"], ["UBE2C", "0.399", "1.30E-04", "6.31E-04"], ["CCNA2", "0.472", "4.90E-06", "4.37E-05"], ["CENPE", "0.542", "5.30E-07", "7.52E-06"]], "row_count": 11, "column_count": 4, "numeric_cells": 31, "header_rows": 1, "locator": "section[12]/table-wrap[1]#Tab2"}}], "gaps": ["asset:data:geo:GSE16011 not downloaded", "asset:data:geo:GSE16011 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Kaplan-Meier survival analysis was performed to compare the OS data in the two cohorts."}}, {"id": "method-2", "family": "group_comparison", "specific": "anova", "label": "Group comparison", "dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.8, "band": "high", "quote": "ANOVA"}}, {"id": "method-3", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Cox regression"}}, {"id": "method-4", "family": "network_analysis", "specific": "ppi_network", "label": "Network / pathway analysis", "dsl_operations": ["build_graph", "centrality_scores", "pathway_enrich"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["edge_list"], "evidence": {"score": 0.7, "band": "medium", "quote": "protein-protein interaction"}}], "targets": [], "gaps": ["method.reader_differs_from_extractor"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["survival_km"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: kaplan_meier."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE16011"], "resolved_accessions": ["GSE16011"], "statements": ["The present study was based on RNA sequencing data from TCGA-LGG (530 cases, Illumina HiSeq 2000 RNA Sequencing platform) and TCGA-GBM (173 cases, Illumina HiSeq 2000 RNA Sequencing platform) and microarray data from GSE16011, which contains 8 cases of normal brain tissue as a control group, 159 cases of GBM, and 117 cases of low-grade gliomas (GPL8542 platform, Affymetrix GeneChip Human Genome U133 Plus 2.0 Array)."], "basis": "The paper names GSE16011 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["survival_km"], "assets": ["source:pmid:32642801", "data:geo:GSE16011", "asset:table:pmid:32642801:1", "asset:table:pmid:32642801:2"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE16011"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:21:04Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": null}, "calls": 3, "usage": {"prompt_tokens": 26451, "completion_tokens": 1545, "cached_tokens": 792}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:32642801", "type": "paper", "label": "pmid:32642801"}, {"id": "source:pmid:32642801", "type": "manuscript", "label": "PMID 32642801 full text"}, {"id": "data:geo:GSE16011", "type": "dataset", "label": "GEO GSE16011"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:32642801", "type": "paper", "label": "pmid:32642801"}, {"id": "source:pmid:32642801", "type": "manuscript", "label": "PMID 32642801 full text"}, {"id": "data:geo:GSE16011", "type": "dataset", "label": "GEO GSE16011"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-32642801", "type": "extraction", "used": ["source:pmid:32642801"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE16011", "type": "accession_resolution", "used": ["data:geo:GSE16011"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:32642801", "parent_hash": "sha256:70bb23e4b39e476b6ac22c0c595bb72e1dcad18f0a00b746fa0813963fc6664a", "fork_of": null, "generation": 7}, "gaps": ["asset:data:geo:GSE16011 licence not read", "asset:data:geo:GSE16011 not downloaded", "execution.not_run", "method.reader_differs_from_extractor", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "rna_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["SERINC2 in gliomas is not fully understood. RNA-sequencing data from The Cancer Genome Atlas (TCGA) (53"], "order_basis": "paper_text_order:318", "id": "assay:1"}, {"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["cases of glioblastoma multiforme (GBM)) and microarray data from Gene Expression Omnibus (GEO) (Acc"], "order_basis": "paper_text_order:463", "id": "assay:2"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["survival_km"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Kaplan-Meier survival analysis was performed to compare the OS data in the two cohorts."], "order_basis": "consumes_earlier_output", "id": "assay:3"}]},"meta":{"api_version":"v1","automation_ladder_snapshot":"ba34b49490d9bfaf","automation_ladder_caveats":["Method extraction is rule-based and has no hand-judged accuracy sample. Evidence bands order textual support; method agreement intervals are null (n=0), never probabilities. Work-type validation does not validate methods.","Operation coverage describes only explicitly named methods. It does not prove a complete protocol, compatible parameters, successful compilation or re-execution. Unrecognised or ambiguous methods require review.","Data reachability is a textual accession or public-data statement. No dataset was downloaded or checked for access, completeness or licence.","Capabilities are planning states seeded from the dated equipment register. No bench ownership, completed quote or partner booking is inferred. Procurement counts are dependencies, not guaranteed replications or financial returns.","Tier and blocker counts are deterministic assessments of this corpus, not measured agreement. R3 is reserved for procurement; unresolved methods and data require human work (R4). The most restrictive axis wins, with capability, method, data as tie-breaks. Resolving one blocker can leave another at the same tier."],"engine":"corpus_engine","engine_provider":"rule_based_v1+lex99e1195c7d6f","run_id":"run-20261023T122449232913","source":"esearch","source_detail":"PubMed mirror biomed_pubmed (read-only)","run_status":"complete","imported_at":"2026-11-03T20:16:52+00:00","generated_at":"2026-11-04T02:14:44+00:00","total_papers":5529,"total_assays_tracked":29,"automatable_assay_families":6,"validated":true,"caveat_count":9,"blocking_caveats":5,"caveats":[{"code":"low_evidence_dominates","basis":["4,152 of 5,529 classifications (75.1%) matched no cue evidence and sit at the 0.05 floor.","34 of 230 data_only calls (14.8%) are in that group."],"claim":"Work type and confidence bands","gloss":"Most records were classified from their title and framing alone, with assay-cue coverage at zero.","detail":"Most classifications in this run rest on no matched evidence at all. At the evidence floor the work type comes from title framing and a fixed prior, not from anything in the paper, so the published work-type split should be read as a rough triage signal rather than a measured distribution. The impact is bounded but not removed: since 2026-10-23 the engine excludes floor-confidence records from the shortlist entirely and publishes them separately as held out, so the recommendation is unaffected even though the census is.","status":"unverified","severity":"high"},{"code":"runtime_is_modelled","basis":["Runtime is summed from published per-assay hour figures. Timing awaits the first executed replication.","4,407 of 5,529 records (79.7%) model to 0.00 hours because no assay was matched, which the ranking then reads as \"cheapest\".","0 of 10 shortlisted records carry a 0.00-hour estimate."],"claim":"Estimated replication runtime","gloss":"The hour figures are estimates built from assay mentions; timing awaits the first executed replication.","detail":"The hour figures are a cost model derived from the bench steps implied by each matched assay family. The first executed replication will supply measured timing. Records without an assay match currently receive a zero-hour model value.","status":"unverified","severity":"high"},{"code":"signal_score_without_citations","basis":["5,529 of 5,529 records (100.0%) have no citation count from the source metadata."],"claim":"Signal score","gloss":"The signal score uses publication-type weight because the mirror supplied zero citation counts.","detail":"The source supplied no citation counts for any record in this run, so the signal score is publication-type weight only. The citation term of the ranking is inert here, and the shortlist is ordered by publication type alone.","status":"unverified","severity":"high"},{"code":"abstract_absent","basis":["1,667 of 5,529 records (30.2%) carry no abstract at all."],"claim":"Evidence base for classification","gloss":"Some records contain a title and publication type only, defining the available classification evidence.","detail":"Where the mirror contains a title and publication types only, those fields define the classifier evidence. A methods section is required for fuller automated and human review.","status":"unverified","severity":"medium"},{"code":"classifier_agreement_measured","basis":["Published two-way decision agreement 77.7% (310 of 399 decidable records) from a stratified hand-check of 438 real records.","Three-way diagnostic agreement 73.9% (288 of 390 decidable records).","data_only agreement 75.2% (100 of 133 decidable).","48 record(s) could not be decided from title and abstract and were excluded from the denominator.","56 analysis-only records were published under another work type, so the data_only share is not an upper bound."],"claim":"Published automatable decision","gloss":"This figure has been checked against a human reading the same papers, so we know how often it is right.","detail":"The published automatable / not-automatable distribution comes from a rule-based classifier that was hand-checked against a fixed ground-truth definition. The agreement rates below are measured, not estimated. The three-way work type remains a diagnostic and is reported separately.","status":"measured","severity":"high"},{"code":"llm_comparison_not_measured","basis":["rule_based_v1+lex99e1195c7d6f produced 5,529 of 5,529 classifications.","Measured on 438 labelled records; these are RULE-BASED figures, not model results."],"claim":"Rule-based versus LLM agreement","gloss":"Every number here is the rule engine’s own. Model comparison begins when a working API credential is connected and measured.","detail":"The published two-way decision agreed with a human reading on 310 of 399 decidable records (77.7%). The diagnostic three-way label agreed on 288 of 390 decidable records (73.9%). Every percentage in this run belongs to the rule engine. Model comparison begins when a working API credential is connected and measured.","status":"not_measured","severity":"high"},{"code":"confidence_is_a_band","basis":["low band: 135 of 210 hand-judged records were correct, 64.3% [57.6, 70.5] (95% CI).","medium band: 80 of 104 hand-judged records were correct, 76.9% [68.0, 84.0] (95% CI).","high band: 73 of 76 hand-judged records were correct, 96.0% [89.0, 98.7] (95% CI).","A fitted calibrated probability was built, measured and withdrawn: it overstated held-out accuracy and reorders nothing."],"claim":"Confidence band and evidence score","gloss":"The confidence band carries a measured accuracy interval; 0.85 represents relative rank strength.","detail":"Confidence on this run is a BAND plus its measured accuracy interval. The number stored alongside each record is a monotone evidence score that orders records; 0.85 represents relative rank strength. A fitted probability was withdrawn after it overstated held-out accuracy. Threshold on the band.","status":"measured","severity":"medium"},{"code":"three_way_split_is_diagnostic","basis":["The corpus is published at the two-way decision: automatable or not-automatable. The three-way split (data_only / physical / mixed) is published as a diagnostic with its measured reliability attached, not as a claim, because the rule engine's `mixed` call cannot be defended.","The engine called 22 record(s) mixed; 10 matched the human judgement (45.5%, 95% CI 26.9-65.3).","The engine's `mixed` call is right on 10/22 hand-judged records (45.5%, 95% CI 26.9%-65.3%); a constant `physical` guess scores 36.4%.","The engine's `mixed` call does not reliably beat a constant `physical` guess on the hand-judged records it labels mixed.","The sign of that difference flips between two independent samples, so the three-way refinement is not demonstrably informative.","The mixed stratum contributes a disproportionate share of errors relative to its size.","At title-only depth the physical/mixed split collapses: a title says that work was done, not whether it was also analysed."],"claim":"The published decision is two-way","gloss":"The three-way split is shown for diagnosis only. The published split is two ways.","detail":"Count and filter the corpus on automatable versus not-automatable. The data_only / physical / mixed split remains an internal engine diagnostic because the mixed call has lower measured reliability.","status":"measured","severity":"medium"},{"code":"automatable_flag_unproven","basis":["6 of 29 assay families are marked automatable now: meta_analysis, machine_learning, survival_analysis, pca, molecular_docking, differential_expression.","The flag is a rule over assay family and work type; validation begins with the first executed replication.","It inherits the 75.2% data_only agreement rate, because the flag requires the record to be analysis-only."],"claim":"Automatable now","gloss":"This flag marks assay families the rules classify as data-only. The first executed replication will validate it.","detail":"This flag marks families the rules consider replicable from data alone. Its validity depends on the analysis-only classification and will be measured through an executed replication.","status":"unverified","severity":"medium"}],"confidence_policy":"band_with_measured_interval","confidence_contract":{"policy":"band_with_measured_interval","summary":"Confidence is reported as a BAND with a measured accuracy interval. The raw evidence score supplies monotone ordering. A fitted point estimate was withdrawn after it overstated held-out accuracy.","evidence_score":"A monotone evidence score in [0,1] built from cue mass, axis separation and text coverage. Use it to order records. Interpret 0.85 as relative rank strength.","confidence_band":"low | medium | high. Consumers threshold on this value.","band_accuracy":"Wilson 95% interval on the measured agreement of the hand-judged records in this band.","calibrated_confidence":"WITHDRAWN. Reintroduction requires held-out evidence demonstrating reliable estimates across every bin."},"band_accuracy":{"low":{"n":210,"low":0.576,"band":"low","high":0.7046,"agree":135,"accuracy":0.6429},"high":{"n":76,"low":0.8903,"band":"high","high":0.9865,"agree":73,"accuracy":0.9605},"medium":{"n":104,"low":0.6795,"band":"medium","high":0.8397,"agree":80,"accuracy":0.7692}},"provider":"rule_based_v1+lex99e1195c7d6f","lexicon_id":"99e1195c7d6f","contract_published_at":"2026-10-23T12:25:29.022232+00:00","confidence_is_band":true,"confidence_is_probability":false,"decision_taxonomy":"two_way","decidable_fraction_two_way":0.8854,"decidable_fraction_two_way_low":0.8565,"decidable_fraction_two_way_high":0.9143,"decidable_fraction_three_way":0.8586,"decidable_fraction_three_way_low":0.8287,"decidable_fraction_three_way_high":0.8884,"decidable_population":5529,"validation_sample_size":438,"three_way_cost_fraction":0.0268,"three_way_cost_records":148,"decision_counts":{"automatable":230,"not_automatable":5299},"decision_split":{"automatable":{"count":230,"share":0.04159884246699222},"not_automatable":{"count":5299,"share":0.9584011575330078}},"diagnostic_work_type_counts":{"mixed":24,"physical":5275,"data_only":230}}}